Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Director, Business Growth & Enablement is responsible for leading capability building initiatives within the Development & Clinical Sciences (DCS) organization. The ideal candidate understands the drug development lifecycle, has worked in rapidly growing organizations and knows how to implement new ways of working. The Growth & Enablement function will create a roadmap for DCS and lead execution of the growth strategy. The successful candidate will draw upon their experience to: Work with leaders to create a strategic roadmap that identifies and sequences capabilities-building into a multi-year plan. Serve as a champion for the DCS growth and enablement vision and link capability building initiatives to the strategic roadmap. Develop a team to drive strategic enablement initiatives, build sustainable capabilities and foster engagement across DCS. Create a leadership dashboard that reinforces strategic priorities, shares progress, identifies risks and highlights corporate dependencies. Be a role model for RevMed Core values.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director